Liposomal nanocarriers for plasminogen activators

S Koudelka, R Mikulik, J Mašek, M Raška… - Journal of controlled …, 2016 - Elsevier
Several plasminogen activators (PAs) have been found effective in treating different
thromboembolic diseases. However, administration of conventional thrombolytic therapy is …
被引用次数：73 相关文章

Liposomal nanocarriers for plasminogen activators

S Koudelka, R Mikulik, J Mašek, M Raška… - Journal of Controlled …, 2016 - infona.pl
Several plasminogen activators (PAs) have been found effective in treating different
thromboembolic diseases. However, administration of conventional thrombolytic therapy is …

[引用][C] Liposomal nanocarriers for plasminogen activators

S Koudelka, R Mikulik, J Masek, M Raska… - Journal of Controlled …, 2016 - jglobal.jst.go.jp
Liposomal nanocarriers for plasminogen activators | Article Information | J-GLOBAL Art J-GLOBAL
ID:201602243223416166 Reference number:16A0906086 Liposomal nanocarriers for …

Liposomal nanocarriers for plasminogen activators

S Koudelka, R Mikulik, J Mašek… - … : official journal of …, 2016 - pubmed.ncbi.nlm.nih.gov
Several plasminogen activators (PAs) have been found effective in treating different
thromboembolic diseases. However, administration of conventional thrombolytic therapy is …

Liposomal nanocarriers for plasminogen activators

S Koudelka, R Mikulík, J Mašek, M Raška… - 2016 - med.muni.cz
Several plasminogen activators (PAs) have been found effective in treating different
thromboembolic diseases. However, administration of conventional thrombolytic therapy is …

Liposomal nanocarriers for plasminogen activators

S Koudelka, R Mikulík, J Mašek, M Raška… - Journal of Controlled …, 2016 - is.muni.cz
Several plasminogen activators (PAs) have been found effective in treating different
thromboembolic diseases. However, administration of conventional thrombolytic therapy is …

Liposomal nanocarriers for plasminogen activators.

S Koudelka, R Mikulik, J Mašek, M Raška… - Journal of Controlled …, 2016 - europepmc.org
Several plasminogen activators (PAs) have been found effective in treating different
thromboembolic diseases. However, administration of conventional thrombolytic therapy is …

Liposomal nanocarriers for plasminogen activators

S Koudelka, R Mikulík, J Mašek, M Raška… - 2016 - med.muni.cz
Several plasminogen activators (PAs) have been found effective in treating different
thromboembolic diseases. However, administration of conventional thrombolytic therapy is …

[引用][C] Liposomal nanocarriers for plasminogen activators

S Koudelka, R Mikulik, J Mašek, M Raška… - 2016